Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou, Shuo Li, Yi Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24

Showing 24 citing articles:

Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Identification of Promising Lung Cancer Drug Targets from Human Plasma Proteins: Mendelian Randomization,Single-Cell Rna Sequencing Analysis
Weijie Yu, Xiaodong Shao, Zhou-lin Miao
(2025)
Closed Access
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash
Cancers (2025) Vol. 17, Iss. 5, pp. 880-880
Open Access
BiSpec Pairwise AI: guiding the selection of bispecific antibody target combinations with pairwise learning and GPT augmentation
Xin Zhang, Huiyu Wang, Chunyun Sun
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 3
Towards precision medicine: design considerations for nanozymes in tumor treatment
Xinqiao Li, Jinpeng Hu, Q Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Cardiovascular Disease Risk Factors, Immune Checkpoints and Tregs
Ying Shao, Fatma Saaoud, Keman Xu, et al.
Advances in biochemistry in health and disease (2024), pp. 51-93
Closed Access | Times Cited: 2
Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma
Damayanti Das Ghosh, Hannah G. McDonald, Rajeswari Dutta, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1785-1785
Open Access | Times Cited: 2
Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma
Feng Ju, Dawei Wang, Lan Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
IMMUNE EVASION IN CANCER IS REGULATED BY THE TUMOR-ASOCIATED MACROPHAGES (TAMS): TARGETING TAMS
Megan Jung, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 1-17
Closed Access | Times Cited: 1
A Terpenoid-Rich Fraction of <em>Inula viscosa</em>: Its Chemical Composition, Antioxidant Capacity, and Anticancerous Effects Against Human Lung Cancer Cells
Fatiha Seglab, Mazen Abou Assali, Thoraya AlYafei, et al.
(2024)
Open Access | Times Cited: 1
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression
Ying Shao, William Y. Yang, Gayani Nanayakkara, et al.
International Journal of Drug Discovery and Pharmacology (2024), pp. 100022-100022
Open Access | Times Cited: 1
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
Dmitri Loukinov, Amanda L. Anderson, Mikayel Mkrtichyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5976-5976
Open Access | Times Cited: 2
Current Status and Progress in the Treatment of Malignant Pleural Effusion in Lung Cancer
雨家 谷
Advances in Clinical Medicine (2023) Vol. 13, Iss. 08, pp. 13464-13473
Closed Access | Times Cited: 2
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models
Pietro Delcanale, Manuela Maria Alampi, Andrea Mussini, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2776-2776
Open Access | Times Cited: 2
Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
Quanqing Li, Guangxin Zhang, Hao Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study
Chengliu Lv, Yahua Wu, Weiwei Gu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Chemical Composition, Antioxidant Capacity, and Anticancerous Effects against Human Lung Cancer Cells of a Terpenoid-Rich Fraction of Inula viscosa
Fatiha Seglab, Mazen Abou Assali, Thoraya AlYafei, et al.
Biology (2024) Vol. 13, Iss. 9, pp. 687-687
Open Access
Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma
Sixuan Wu, Junfan Pan, Qihong Pan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Causal relationship between gut microbiota and lung squamous cell carcinoma: a bidirectional two-sample Mendelian randomization study
Weijian Song, Jianwei Shi, Minjun Du, et al.
Postgraduate Medical Journal (2024)
Closed Access
Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications
Ruiqi Chen, Hongbiao Xu, Elfira Jurat, et al.
Organ medicine. (2024)
Open Access
Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access
Immunotherapy in cancer: Where we are and what the future brings?
Krsek Antea, Krpina Kristina, Samarzija Miroslav, et al.
Trends in Immunotherapy (2023) Vol. 7, Iss. 2, pp. 2186-2186
Open Access | Times Cited: 1
Anoikis-related gene signature predict the prognosis and immune infiltration characterization of lung adenocarcinoma
Xiu-He Kang, Mengyu Zhang, Rui Li, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top